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Monoclonal antibodies to human renal basement membranes: Hetero-
genic and ontogenic Changes. Monoclonal antibodies reactive with renal
basement membranes have been developed following immunization of
mice, subsequent hybridization of spleen cells with the NSI cell line,
and appropriate cloning techniques. The antibody reactivity and speci-
ficity of clonal supernatants and ascites fluid were evaluated by indirect
epifluorescence-phase contrast microscopy on sections of human kid-
ney and other tissues. This permitted characterization of clones based
on the immunohistochemical phenotype of the antibody in binding to
anatomically defined basement membranes as well as to site-specific
loci or regions within the membrane. Based upon unique immunohisto-
chemical reactivity, nine different antibodies were developed: two
reacting with known components of basement membrane by ELISA
(MBM4-type IV collagen and MBM2O-fibronectin) and seven failing to
react with these or other defined antigens (fibronectin, laminin, or types
IV and V collagen). Among the latter group, five immunohistochemical
phenotypes were identified in mature human kidney: (1) MBM7 and
MBMI5 reacted with the lamina densa, Bowman's capsule, tubular
basement membrane, and vascular walls. (2) MBMIO and MBMI4 fixed
in a double-linear granular pattern to each side of the tubular basement
membrane and Bowman's capsule as well as within the mesangiurn and
in vascular basement membranes but not the glomerular basement
membrane (GBM). (3) MBMI 1 identified sites along the internal aspect
of Bowman's capsule and the tubular basement membrane but not
within the glomerulus. It also stained type I but not type II skeletal
muscle. (4) MBMI2 reacted with the full thickness of Bowman's
capsule, the mesangium and stalk region, the tubular basement mem-
brane, but not the GBM. (5) MBM2I, which had the most restricted
binding in tissue, identified an antigen in the tubular basement mem-
brane of the proximal tubules. During nephron formation type IV
collagen and fibronectin were redistributed from the undifferentiated
mesenchyme to appear with induction within the "S" shaped anlage, in
latter stages in the region of the primitive GBM, and in the mature
glomerulus in the mesangium and the GBM. This pattern seen in the
human kidney is similar to that described in the mouse. Changes in the
distribution of antigens identified by other monoclonal antibodies were
observed during ontogenesis. Eight monoctonal antibodies recognized
antigens in fetal GBM, but only four of these reacted with mature GBM.
Certain antibodies (MBM4, MBMIO, MBMI4, MBMI2) had a broad
range of reactivity with basement membranes in different tissues,
whereas others (MBM7, MBM15, MBM1 I) demonstrated more limited
reactivity; MBM2I was the most restrictive of all reacting only with the
proximal tubular basement membrane. Specific basement membranes
in different tissues shared the same antigens as evidenced by similar
profiles of reactivity with various antibodies. Basement membranes in
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human kidney are heterogeneous with respect to constituent antigens
and undergo changes during ontogenesis. These studies provide the
foundation for further studies that will permit mapping and character-
ization of immunoreactive basement membrane components.
Anticorps monoclonaux a les membranes basales renales humains:
Modifications des heterogénique et ontogénique. Des anticorps mono-
clonaux réagissant contre des membranes basales rénales ont été
développés après immunisation de souris, puis hybridation de cellules
spéniques avec la lignee cellulaire NS 1, et techniques de clonage
appropriées. La réactivité et Ia spécificité des anticorps des surnageants
de clonage et de liquides d'ascite ont été évaluées par microscopie a
contraste de phase avec épifluorescence indirecte sur des coupes de
rein et d'autres tissus humains. Cela a permis La caractérisation de
clones fondée sur le phenotype immunohistochimique des anticorps se
liant aux membranes définies anatomiquement, et a Ia spécificité de site
pour certains lieux ou certaines regions de Ia membrane. En utilisant
uniquement Ia réactivité immunohistochimique, neuf anticorps differ-
ents ont été dCveloppés: deux réagissant avec des constituants connus
de la membrane basale par ELISA (MBM4-collagene de type IV et
MBM2O-fibronectine) et sept ne reagissant pas avec ces antigenes ou
d'autres (fibronectine, laminine, ou collagene de type IV et V). Dans ce
dernier groupe, cinq phenotypes immunohistochimiques ont été identi-
flés dans du rein humain mature: (1) MBM7 et MBM15 reagissaient
avec Ia lamina densa, la capsule de Bowman, Ia membrane basale
tubulaire, et les parois vasculaires. (2) MBMIO et MBMI4 se fixaient
avec un aspect granulaire en double contour a chaque côté de Ia
membrane basale tubulaire et de Ia capsule de Bowman, ainsi que dans
le mésangium et sur les membranes basales vasculaires, mais non sur Ia
membrane basale glomérulaire (GBM). (3) MBM 11 a permis l'identifi-
cation de sites le long de Ia partie interne de Ia capsule de Bowman et de
Ia membrane basale tubulaire mais non dans le glomerule. II colorait
CgaIement le muscle squelettique de type I mais non de type II. (4)
MBMI2 réagissait avec Ia totalité de l'épaisseur de Ia capsule de
Bowman, le mesangium et Ia region des tiges, Ia membrane basale
tubulaire mais non Ia GBM. (5) MBM2I, qui avait Ia liaison tissulaire Ia
plus réduite permettait Ia localisation d'un antigene dans Ia membrane
basale tubulaire des tubules proximaux. Pendant Ia formation néphroni-
que, le collagéne de type IV et Ia fibronectine étaient redistribués a
partir du mesenchyme non différencié pour apparaitre lors de l'induc-
tion a I'intérieur des structures en forme de "5" aux stades plus tardifs
dans Ia region de Ia GBM primitive, et dans le glomerule mature, dans le
mésangium et Ia GBM. Cet aspect vu dans le rein humain est identique a
celui décrit chez Ia souris. Des modifications dans Ia distribution
d'antigCnes identifies par d'autres anticorps monoclonaux ont été
observées pendant l'ontogenèse. Huit anticorps monoclonaux ont re-
connu des antigCnes dans Ia GBM foetale, mais seulement quatre
d'entre eux ont reagi avec des GBM matures. Certains anticorps
(MBM4, MBM1O, MBM14, MBM12) avaient un large éventail de
rCactivité avec les membranes basales dans différents tissus, tandis que
d'autres (MBM7, MBM15, MBMI1) ont démontré une réactivité plus
Iimitée; MBM2I était le plus restreint de tous, reagissant seulement
avec Ia membrane tubulaire proximale. Des membranes basales specifi-
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ques dans différents tissus partageaient les mémes antigènes, comme
cela été montré par des profils de réactivités identiques avec des
anticorps vanes. Les membranes basales du rein humain sont hétéro-
genes en cc qui concerne les antigènes les constituant et subissent des
modifications pendant l'ontogenese. Ces etudes constituent Ia base
pour des travaux ultérieurs qui permettront de localiser et de caractér-
iser définitivement biochimiquement les constituants immuno-réactifs
des membranes basales.
Ultrastructural studies of the kidney suggest that the glomer-
ular capillary wall is a relatively simple structure composed of
fenestrated endothelial cells, epithelial cells, and an interposed
glomerular basement membrane (GBM). The latter contains a
homogeneous electron-dense material—the lamina densa, and
adjacent lucent zones—the lamina rara interna and externa. The
capillary is unique in that the centrolobular part of the wall is
not separated from the lumen by a defined GBM but contains
mesangial matrix and cells [1, 21. Recently, discrete glycopro-
tein and collagen antigens in site-specific arrays along the
glomerular capillary wall and within the mesangium were
demonstrated by immunohistochemical techniques [3—11]. In
addition, GBM isolated by sonication or detergent-extraction is
heterogeneous with respect to its constituent antigens contain-
ing the same components as demonstrated in intact tissue,
indicating a degree of complexity not appreciated previously
[12]. Certain antigens, type IV procollagen, type V collagen,
and fibronectin, were found along the internal aspect of the
GBM continuous with antigenic sites in the mesangium [12],
suggesting an anatomic contiguity between these regions not
recognized by conventional electron microscopy but similar to
that described after guanidine incubation [131. In contrast, sites
reactive with Goodpasture's antibody, and heterologous anti-
body to bovine lens capsule type IV collagen were demonstrat-
ed within the more central regions of the GBM, whereas laminin
was located on either side of the lamina densa [3—5, 12]. The
demonstration of another component in the lamina rara, he-
paran sulfate, is of particular relevance to the charge-selective
barrier function of the capillary wall [14]. Other basement
membranes of the kidney, the tubular basement membrane
(TBM), Bowman's capsule, and vascular basement mem-
branes, have received less study, although a similar heterogene-
ity exists with respect to the presence of defined antigens such
as laminin and collagen types IV and V [3, 4].
Considerable data has been presented which suggests that a
number of different defined constituents of the basement mem-
branes may be involved in the formation of glomeruli and
tubules. Included are the unique collagens of the membrane [15,
16], fibronectin [17], laminin [18], glycosaminoglycans linked to
proteins as proteoglycans [17, 19], and a sialic acid rich
glycoprotein [17, 20].
This paper describes the development and characteristics of
monoclonal antibodies reactive with the basement membranes
of human kidney and other organs supporting the concept that
these extracellular membranes are heterogeneous with respect
to constituent antigens. In addition, unique changes were
observed in basement membranes during ontogenesis.
Methods
Antigens. Three BM preparations were used for immuniza-
tion: particulate GBM; collagenase-digested GBM; and citrate
(pH 3.2) extracted renal cortical basement membranes,
GBM and collagenase-digested GBM. Normal human kid-
neys were obtained within 8 hr of accidental death and pre-
served at —20°C. Glomeruli were isolated by graded sieving and
GBM separated after ultrasonic disruption at 4°C as previously
reported [211 in the presence of sodium azide (0.02%), ethylene-
diamine tetraacetic acid (5 mM), n-ethylmaleimide (0.02%), and
phenyl methyl sulfone fluoride (0.002%). Collagenase-digested
GBM was prepared by a modification of the method of Spiro
[22] and Lehotay [23], by incubating lyophilized GBM with
collagenase (Advance Biofactures Corporation) (10 U/mg) in
0.05 M Tris-HC1 buffer at pH 7.40 containing 0.01 M calcium
chloride for a period of 72 hr at 37°C; additional collagenase (10
U/mg) was added after 24 and 48 hr. In one experiment, TBM
was isolated by sieving.
Citrate (pH 3.2) extracts of renal cortical BM. Cortical
fragments were separated from a normal human kidney with a
razor blade at 4°C, suspended and washed in isotonic saline
containing 0.01 M phosphate (pH 7.20) and the metabolic
inhibitors indicated above (PBS-I), and homogenized at 4°C in a
Virtis homogenizer for 45 sec. The sedimented cortical mem-
brane fraction was separated by centrifugation, suspended in a
volume of citrate buffer (0.02 M, pH 3.2) equivalent to nine
times the pellet volume, and shaken for 2 hr at 37°C. The
supernatant was concentrated (Amicon YM1O) to a 20-ml
volume and dialyzed against PBS-I. The proteins were precip-
itated overnight using 60% saturated ammonium sulfate at 4°C,
washed, and redissolved in and dialyzed against PBS-I. Ap-
proximately 50 mg of protein in 5.0 ml of PBS-I was applied to a
lO-ml column of sepharose 4B with bound Ricinis Communis
agglutin 120 (RCA 120, lot no. 00516, Vector Laboratories,
Inc., Burlingame, California), pre-washed with 30 ml of PBS-I,
and then eluted with 0.20 M lactose in PBS-I. The eluate which
contained 8 to 11% of the material applied to the column was
dialyzed against 0.05 M ammonium bicarbonate and lyophilized.
The material contained five to six bands on a 5 to 15% gradient
SDS polyacrylamide gel [24] and showed at least four immuno-
precipitin lines by double-diffusion against rabbit antiserum to
GBM. This relatively crude preparation of basement membrane
components is a consequence of endogenous peptidase(s) ac-
tive at pH 3.2, since no antigenic components are released in
the presence of pepstatin (1 g/ml) (Tokyo Peptide Institute).
Immunization. Balb/c female mice, bred in the mouse colony
of the Department of Laboratory Medicine and Pathology at the
University of Minnesota, Minneapolis, Minnesota, were immu-
nized by an intraperitoneal injection of 100 to 200 g of one of
three preparations described above homogenized in complete
Freund's adjuvant (Grand Island Biological Co.), followed by at
least two subsequent immunizations in PBS at intervals of 14 to
21 days.
Hybridization and cloning. Four days after the final immuni-
zation, spleen cells in Dulbecco's modified Eagle medium
(DMEM, Microbiological Associates) were fused with the
Balb/c myeloma cell line P3-Nsl-Ag4-l (NSI) (obtained from
Dr. Tucker LeBien, University of Minnesota) in 50% polyethyl-
ene glycol (PEG 1000 J. T. Baker Chemical, Co.) [25]. The cells
were grown at clonal density in 96 well microtiter plates
(Costar) in HAT medium containing Littlefield's concentrations
of hypoxanthine, aminopterin, and thymidine [26]. Visible
hybrid colonies appeared 7 to 21 days after fusion and the
supernatants were screened for antibody as discussed below.
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Table 1. Reactivity of monoclonal antibodies with human renal basement membranes
Monoclonal
antibody
Ig subclass
light chain
Sites reactive with BM by indirect immunofluorescence
GBM Mesangium
Bowman's
capsule TBM
Vessel
Intima Wall
MBM4b
MBM2Ob
MBM7
MBM15
MBM1O
MBM14d
MBMI2
MBMII
MBM21
IgG2b (k)
IgG1 (k)
IgG1 (k)
IgG1 (k)
lgG1 (k)
lgG1 (k)
IgG1 (k)
IgG21, (k)
IgG! (k)
I + (I)
1+ (I)
3+ (LD)
3+ (LD)
3 +
2+
2+ (Gr)
2+ (Gr)
2+
3 + (FT)
1+ (Int)
1+ (tnt)
2+ (Gr)
2+ (Gr)
3+ (FT)
2+ (tnt)
3 +
1+
1+
2+ (Gr)
2+ (Gr)
3+
2+
2+
I +
2+
3 +
3+
3+
2+ (Gr)
2+ (Or)
1+
Abbreviations: I, internal aspect of the GBM continuous with the mesangium; tnt, internal region of Bowman's capsule; LD, lamina densa; Or,
granular distribution with double-linear configuration on TBM and Bowman's capsule; FT, full thickness of Bowman's capsule.
a The intensity of positive immunofluorescence is indicated as 1+, 2+, or 3+.
b MBM2O reacts with fibronectin and MBM4 with type IV collagen by ELISA. All other antibodies do not react with laminin, fibronectin, types
I, III, or IV collagens, or plasma.
MBM15 is phenotypically similar to MBM7 but in addition reacts with tubular droplets in human fetal kidney.
d MBMI4 is a similar phenotype to MBMIO on adult kidney but also reacts with tubular brush border in fetal kidney.
Cells from microtiter wells producing antibody of interest as
determined by immunofluorescence screening were subcloned
by limiting dilution (0.5 cell per well) onto a feeder layer of
Balb/c female x-irradiated spleen cells in 96 well microtiter
plates (approximately 2.5 x feeder cells per well) [27].
Clones appeared 7 to 21 days after seeding. Supernatants from
the wells of each limiting dilution were again screened for
antibody production by indirect immunofluorescence and se-
lected clones propagated, subcloned, or frozen. Positive sub-
clones selected for antibody production were grown to culture
volume and injected into pristane-primed Balb/c female mice
[28] and ascites fluid harvested 7 to 14 days after injection.
Determination of antibody reactivity. (1) Supernatants from
all wells containing a macroscopic clone were screened for
antibody binding on targets of normal human kidney by indirect
immunofluorescence. Sections (2 to 4 ) of human kidney fixed
in wells on glass slides (Zeus Scientific Co., Raritan, New
Jersey) were layered with supernatants and incubated at room
temperature for 30 mm. Slides were then washed with PBS and
reacted with fluorescein-isothiocyanate (FITC) goat antimouse
Ig (y, , a, K, X chain reactive) (Cappel Laboratories, Inc.,
Cochranville, Pennsylvania) [29].
(2) For Ig subclass determination, kidney sections were
layered with supernatant or ascites fluid, and reacted first with
human plasma-absorbed rabbit antisera to mouse IgG1, IgO2a,
1gM, IgA, K and X light chains (Litton Bionetics, Inc., Kensing-
ton, Maryland) and then stained with human and mouse plasma-
absorbed FITC-labeled goat anti-rabbit IgG (Cappel Labora-
tories, Inc., Cochranville, Pennsylvania).
(3) Supernatant and ascites fluid were also evaluated for
reactivity with the following antigens by ELISA [30, 31]:
fibronectin (provided by Dr. Leo Furcht, University of Minne-
sota); placental types IV and V collagen isolated as described
previously [32—35]; types I and III collagen isolated from human
skin [36]; laminin [37] (courtesy of Dr. Hynda Kleinman,
National Institutes of Dental Research); type IV (monomeric)
collagen (provided by Dr. Jon Sauk, University of Minnesota)
derived from bovine lens capsule [38]; human plasma; and
human plasma cryoprecipitate. The specificity of the collagen
and glycoprotein antigens was verified by reactivity with affini-
ty-purified rabbit antibodies to type I collagen, type III colla-
gen, type IV procollagen, type V collagen, and laminin [3, 4]
(provided by Drs. J. M. Foidart and George R. Martin, National
Institutes of Health); fibronectin (Dr. Leo Furcht, University of
Minnesota); and type IV collagen (bovine lens capsule) provid-
ed by Dr. Nicholas Kefalides, University of Pennsylvania,
Philadelphia, Pennsylvania) [3]. In addition, monoclonal anti-
bodies were also absorbed with human plasma and albumin in
fluid phase and in solid phase after glutaraldehyde cross-linkage
[39].
Immunohistochemical methods. Normal human kidney tis-
sue samples were obtained from 15 patients (ages 2 weeks to 71
years) at the time of nephrectomy for renal tumors, from biopsy
specimens of normal donor kidneys prior to transplantation and
from heart-beating cadavers. Other tissue samples were also
obtained from the latter source. Normal skin and muscle tissue
was available as previously reported [40, 41]. Nine fetal kidneys
of gestational ages 11 to 32 weeks were obtained at the time of
necropsy after legal abortion. A kidney from a premature
infant, gestational age 29 weeks, who died of respiratory
disease 3 weeks later was also obtained at autopsy. Permission
to obtain tissue samples for this investigation was obtained from
the Committee on Use of Human Subjects in Research, Univer-
sity of Minnesota. Detergent-isolated GBM was prepared as
previously described [12]. Tissue samples were frozen in iso-
pentane precooled in liquid nitrogen and sectioned at 4 m in a
Lipshaw cryostat. After air-drying, sections were fixed in
acetone for 10 mm, washed three times with PBS (pH 7.4),
overlaid with approximately 20 .d of an appropriate dilution of
the monoclonal supematant or ascites fluid, washed with PBS,
and then reacted with FITC-conjugated goat anti-mouse Ig (y,
, a, K, X chain specific) [29]. In some instances FITC-labelled
F(ab')2 rabbit anti-mouse IgG (heavy and light chains) (Cappel
Laboratories) was used, but results were similar to those
observed with non-F(ab')2 reagents. Subclass specific reagents
to mouse IgG1, IgG2a, 1gM, IgA, K and light chains were also
used after application of each monoclonal antibody, followed
by human and mouse plasma-absorbed FITC-conjugated goat
anti-rabbit IgG.
Controls included the following hybridoma-derived monoclo-
Fig. 1. Immunofluorescence of human kidney
sections stained with monoclonal antibodies.
A and B MBM4 (anti-collagen IV) stains in
the TBM, the full thickness of Bowman's
capsule, the mesangium, and the internal
aspect of the GBM. (A x140, B x360) C
MBM7 stains in the lamina densa (arrows)
and not the mesangium (M). (x 1030) D The
same region as seen by phase-contrast
microscopy. The arrows denote the same
region of the lamina densa as depicted in C.
An epithelial cell nucleus (E) is observed. (C,
D x 1030) E MBMJ5 in a similar pattern with
the GBM, the internal aspect of Bowman's
capsule, the TBM, but not the mesangium.
(X370) F MBMI5 stains in the smooth muscle
basement membrane of the arteries including,
as illustrated here, the afferent/efferent
arterioles supplying two glomeruli. (x 140) G
and H Section of detergent-isolated GBM
stained with MBM7 and viewed by
immunofluorescence (G) and phase-contrast
microscopy (H). The intensity and distribution
of reactivity in the lamina densa (arrows) is
similar to that observed in intact tissue noted
in C and D above. Note the absence of cells.
The mesangial matrix (M) is negative. (x820)
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nal antibodies followed by the appropriate FITC-labeled anti-
mouse Ig [29]: OKT3 (IgA2a), OKT4 (IgG2), OKT8 (IgG2a),
and OKM1 (IgG2b) (Ortho Pharmaceutical Corporation, Rari-
tan, New Jersey); TA1 (IgG2) reactive with T lymphocytes and
monocytes and BAI (1gM) reactive with B lymphocytes (pro-
vided by Dr. Tucker LeBien, University of Minnesota); and
monoclonal antibodies reactive with IgA1 (IgG3) and IgA2
(IgG2) [421. Myeloma-derived monoclonal Ig were also used as
controls and included UPC1O (IgG2a), MOPC 195 (IgG2b), and
MOPC 104E (1gM) (Litton Bionetics, Inc.). Lymphocytes,
monocytes, and polymorphonuclear leukocytes were obtained
by Ficoll-Hypaque gradient centrifugation as previously report-
ed [29, 431. Muscle adenosine triphosphatase (ATPase) was
evaluated histochemically after preincubation at pH 4.47 [441.
To define specific tubules reacting with monoclonal antibodies
Tissue evaluation. The localization of antibody to site-specif-
ic loci in basement membrane and in mature kidney using high
resolution phase contrast-epiimmunofiuorescent microscopy
was carried out as previously described [3, 5, 12j. We have
found it convenient to describe the developing glomerulus in
fetal kidney in the following five stages:
Stage 0: The aggregation of undifferentiated mesenchymal
cells of the metanephros around the ampulla of the dividing
ureteral bud to form the renal vesicle; stage 1: the reorganiza-
tion of the cells of the vesicle to form the S" shaped structure
and the penetration of a cleft in this structure by a mesenchymal
blood vessel; stage 2: the earliest steps in the differentiation of
the glomerulus through branching of the invading vessel to form
3 to 5 capillary loops; stage 3: the complexity and number of the
glomerular capillary loops increase; a definitive vascular pole is
certain tissue samples were also stained with a rabbit antiserum apparent, but the glomerulus remains immature with character-
to Tamm-Horsfall protein [45]. istic rows of cuboidal epithelial cells covering the capillaries;
ffl*1
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stage 4: the glomerulus resembles the normal adult structure.
As with all mammals, each fetal human kidney reveals the
entire spectrum of glomerular development, since the most
mature glomeruli are present in the cortico-medullary junction,
while the most immature structures are present in the nephro-
genic zone beneath the capsule of the kidney. This unique
feature of renal embryogenesis greatly facilitates the compari-
son of the distributionof antigens in glomeruli of differing stages
of development which are regularly observed in each fetal
specimen. Thus, the nominal age of the fetus or origin for
glomeruli in various stages of development will not always be
indicated in the text.
Results
Reactivity of monoclonal basement membrane antibodies
(MBM) with mature kidney
Nine monoclonal antibodies were produced which reacted
with renal extracellular membranes by indirect immunofluores-
cence on 12 normal human kidneys (> 6 years) (Table 1, Figs. I
and 2). In general, individual monoclonal antibodies reacted
Fig. 2. Immunofluorescence of human kidney
sections stained with monoclonal antibodies.
A MBMIJ reacts with internal aspect of
Bowman's capsule and all TBM but not the
mesangium or GBM. (X 140) B MBMI2 stains
the TBM, the full thickness of Bowman's
capsule, the mesan glum and stalk but not the
GBM. (x350) C and D MBM2I as seen by
immunofluorescence (C) and in combination
with phase-contrast microscopy (D). Note the
positive immunofluorescence along the TBM
of the proximal tubule (PT) where it enters the
glomerulus (0), and the negativity (arrows) of
the GBM, the distal TBM, and Bowman's
capsule where it joins the proximal TBM.
(x382) E, F, and G MBMI4 reacts in a
granular pattern with the mesangium and in a
double linear configuration (arrows) on each
side of Bowman's capsule and the TBM. (A
x148, B x162, C x366)
similarly and with the same intensity using various kidneys.
MBM4, which reacts with the internal aspect of the GBM, the
mesangium, and basement membranes of Bowman's capsule,
tubules, vessel walls, and peritubular capillaries, has specificity
for type IV collagen by ELISA (Fig. IA and B). In addition, the
pattern of immunofluorescence was similar to that previously
described for heterologous antibody to type IV procollagen
isolated from the EHS sarcoma [3]. MBM2O reacted with the
mesangium, the internal aspect of the GBM, the intima of
vessels, and peritubular capillaries. By ELISA, MBM2O dem-
onstrated specificity for fibronectin and also reacted with
cryoprecipitate.
The remaining seven monoclonal antibodies failed to react
with known components of the basement membrane. MBM7
had the same immunohistochemical phenotype as MBM15 on
mature human kidney reacting with the lamina densa, the
internal aspect of the Bowman's capsule, the TBM, and vascu-
lar smooth muscle basement membranes (Fig. 1C to F). By
combination phase-contrast immunofluorescence microscopy,
the immunofluorescence of the GBM appeared to be located
along the epithelial surface of the lamina densa. However,
w
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Table 2. Reactivity of monoclonal antibodies with basement membranes of human fetal and adult kidneysa
Stages of nephron development"
Stage 2 Stages 3 and 4
Stage 0 Stage 1 Early capillary Late capillary Adult
Monoclonal antibody Vesicle S form loop loop kidney
MBM4 (anti-type IV collagen) + + GBM
Mesangium
+
+1—
+
+
+
+
MBM2O (anti-fibronectin) + + GBM
Mesangium
+
+
+
+
+
+
MBM7l5r + + GBM
Mesangium
+
—
+
—
+
—
MBM10-14 + + GBM
Mesangium
+
+
—
+
—
+
MBM12 + + GBM
Mesangium
+
+
-
+
—
+
MBMII + + GBM
Mesangium
+
—
—
+
-
—
MBM21' + + GBM
Mesangium
—
—
—
—
—
—
a Reactivity as evaluated by indirect immunofluorescence is indicated by +; no reactivity by —.
b Bowman's capsule and TBM in fetal and adult kidney reacted with MBM4, MBM7-15, MBM1O-14, MBM12, and MBMII.
a MBMI5 reacted similarly to MBM7 but also reacted with droplets in fetal tubular cells; MBMI4 reacted similarly to MBMIO but also reacted
with fetal tubular brush border.
d MBM21 fixed only to Bowman's capsule of early fetal glomeruli but reacted with proximal TBM of fetal and adult kidney.
MBM15 but not MBM7, reacted with rabbit renal basement
membrane and tubular droplets in fetal human kidney. Immuno-
histochemical studies on cell free, detergent, isolated human
GBM demonstrated strong reactivity of the lamina densa with
MBM7 and MBM15 (Fig. 1G and H).
Both MBMI 1 and MBM12 bound to TBM but not GBM (Fig.
2A and B). However, MBM12 bound to the central and periph-
eral rnesangium whereas MBM1 1 did not react with the glomer-
ulus; the former stained the full thickness of Bowman's capsule
and the latter reacted only with its internal aspect. MBM1 1 did
not bind to the walls of blood vessels in the kidney but reacted
with vessels in all other organs studied (see below). In contrast,
MBM21 had a very restricted localization, binding only to the
TBM of the proximal tubule including the ascending loop of
Henle (Fig. 2C and D). This was confirmed by staining tissue
sequentially with antiserum to Tamm-Horsfall protein and
MBM2I and demonstrating some positive tubules encircled by
MBM21-positive TBM.
MBM1O and MBM14 had similar immunohistochemical phe-
notypes on the human kidney which reacted in a granular
double-linear configuration on each side of the TBM and
Bowman's capsule and in a granular pattern in the mesangium
(Fig. 2E, F, and G). However, MBM14 but not MBM1O reacted
with the brush border of human fetal tubules.
Indirect immunofluorescence using serum from mice immu-
nized with human GBM demonstrates a double-linear staining
on GBM similar to that previously described using rabbit and
sheep anti-GBM [5]. When the kidney was stained concomitant
with MBM4 (which reacted with the internal aspect of the
GBM) and MBM7 (which reacted with the lamina densa), a
typical double-linear immunofluorescence was observed similar
to that observed with heterologous anti-GBM antiserum.
By immunofluorescence, no reactivity with renal basement
membranes was observed using monoclonal antibodies with
other defined specificities (OKT3, OKT4, OKT8, 0KM 1, TA-
1, BA-i, anti-IgA, and anti-IgA2) or with myeloma-derived
monoclonal Ig (UPC1O, MOPC 104E, and MOPC 195).
Reactivity of monoclonal antibodies with human fetal kidney
The binding of individual monoclonal antibodies to human
fetal kidney is summarized in Table 2 and depicted in Figures 3
to 6. Antibody to type IV collagen (MBM4) and fibronectin
(MBM2O) reacted with the basement membrane of the vesicle
(stage 0) and the S-form (stage 1). Similar binding was observed
with the remaining seven monoclonal antibodies which in adult
kidney describe five immunohistochemical patterns (MBM7-15,
MBMIO-14, MBMI2, MBM1 I and MBM21). No reactivity with
adjacent mesenchyme or interstitium was observed. Type IV
collagen and fibronectin were both observed within the vessel
in the cleft of the S-shaped structure (stage 1) and the primitive
afferent arteriole (Figs. 3 and 4).
The primitive GBM of early capillary loops (stage 2) reacted
with all the antibody probes except MBM21 (Figs. 3 to 6). With
glomerular development (stages 3 and 4) there was loss of
reactivity of GBM with MBM1O, MBM14, MBMI2, and
MBM11. Only type IV collagen, fibronectin, and antigen(s)
reactive with MBM7 and MBM15 persisted in the GBM of
stages 3 and 4 and adult glomeruli.
All antibodies except MBM7-l5 and MBM21 reacted with the
mesangium of primitive glomeruli—a finding which, with one
exception (MBM1 1) persisted into adult life. The latter anti-
body, reacted with the GBM of stage 2 glomeruli (Fig. 5). With
the appearance of a recognizable mesangial region (late stage 2,
early stage 3), staining of the GBM disappeared and the
mesangial zone became positive. Reactivity in this site persist-
ed in stage 4 glomeruli of infants and was detected in a child age
1.5 years but was not detected in mature glomeruli of older
children and adults.
In fetal kidneys, cellular immunofluorescence was only ob-
served with MBM20 (anti-fibronectin). Reactivity appeared
! /
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Fig.3. Indirect immunofluorescence micrographs of the reactivity of MBM4 (anti-type IV collagen) with human fetal kidney. A Stage 2 glomerulus
showing negative surrounding interstitium, 1-2+ staining of Bowman's capsule and 3+ staining of the developing glomerular capillary walls
(arrows). (x515) B Stage 3 glomerulus showing intense staining of the mesangium and less intense (1+) reactivity with the peripheral GBM
(arrow). This antibody also reacted with the TBM, Bowman's capsule and the walls of an arteriole (asterisk). (x460)
Fig. 4. Reactivityof MBM2O (anti-fl bronectin) with human glomeruli of differing stages of development. A Vesicle (stage I) showing bright staining
of the membranes of a vessel(V) within the cleft of an S-shaped nephron an/age. Reactivity is also demonstrated with the membranes of the re-
nal vesicle, and tubular and vascular membranes of the surrounding renal mesenchyme. (x 140) B With fort/icr development of the glomerulus
(stage 2), reactivity of the capillary walls, and the surface of visceral epithelial cells (E) appeared. The parietal epithelial cells (P) were negative.(x 140) C A more mature fetal glomerulus (stage 3), demonstrates intense reactivity of the mesangium, the glomerular capillary walls, and
persistent staining of TBM, Bowman's capsule, and interstitial vessels. (x 140) D Higher magnification of an adult glomerulus showing intense
reactivity of the mesangium and less intense (1+) but definite reactivity with the peripheral GBM (arrow). (x460)
around the circumference of each differentiating visceral epithe- In fetal kidneys, TBM and Bowman's capsule reacted with
hal cell of stage 2 glomeruli in the form of bright rings adjacent most of the antibodies, creating a pattern persisting into adult
to the stained GBM (Fig. 4B). No parietal epithelial staining was life. However, MBM21 reacted with the basal lamina of the
noted. In more mature glomeruli the visceral epithelial staining vesicle and S-form and Bowman's capsule of early stage 2
disappeared. glomeruli (Fig. 6). Thereafter, there was a loss of reactivity with
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Fig. 5. Reactivity of MBMII with glomeruli of differing stages of maturity. A In early stage 2 glomeruli this antibody reacted primarily with the
primitive GBM (arrows). (x490) B With the appearance of mesangial region (M) (late stage 2) staining of this region was apparent, and staining of
Bowman's capsule and TBM (T) was more evident. (x 150) C A stage 3 glomerulus showing disappearance of the staining of the GBM and
persistent reactivity of the mesangiurn (M). (x480) D Tissue from an infant 6 months old, showing persistent reactivity of the mesangium,
Bowman's capsule, TBM, and arterial muscle sarcolemma (A). (x 100) E Adult kidney illustrating absence of glomerular (G) staining and
persistence of staining of Bowman's capsule and TBM. (X 190)
the capsule with persistent staining of the proximal TBM.
Vascular reactivity of these antibody probes mirrored that
observed in adult kidneys with the exception that MBM11
stained fetal but not adult arterial walls.
Reactivity of monoclonal antibodies with other tissues
Certain antibodies (MBM4, MBMIO, MBM14, and MBM12)
have a relatively broad range of reactivity with basement
membranes in different tissues, whereas others (MBM7,
MBM15, and MBM1 1) show more limited reactivity (Table 3).
tissue evaluated. A commonality in the reactivity of certain
basement membranes with specific antibodies was also ob-
served. For example, the basement membranes of the hepatic
and splenic sinusoids and muscle sarcolemma reacted with
MBM4, MBM1O, MBM14 and MBM12, MBM2O, but not
MBM7, MBM11, MBM15, and MBM21. In contrast, the base-
ment membranes of the epidermis, alveoli, bronchioles, and
bile ducts were stained by most of the antibodies although there
were differences among them (Table 3). MBM1 1 reacted with
some skeletal muscle fibers but not others; the positive fibers
MBM2 1, which identified the basement membrane of proximal proved to be type I by histochemical staining for ATPase. The
tubules, did not react with basement membranes of any other walls of blood vessels in the nonrenal tissues were stained by all
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Fig. 6. Reactivity of MBM2J with human nephrons, at various stages of development. A An "S '-shaped nephron anlage demonstrating diffuse (1-
2+) staining of the basal lamina. (x450) B Stage I nephron showing increased intensity of staining of the membrane surrounding that portion of
the structure destined to become the proximal tubule (PT), and decreased reactivity with the membranes of the glomerular anlage (G). (x490) C
Stage 3 glomerulus showing negative glomerulus (G), loss of staining of BC. and persistent reactivity with the most proximal portion of the
proximal tubule (PT), at its exit from the glomerulus. (x480) D Typical distribution of reactivity of MBM2I in adult kidney showing reactivity with
only the TBM of proximal tubules. The arrow (PT) marks the exit of a proximal tubule from a glomerulus (be!ov'). (x480)
Table 3. Reactivity of monoclonal antibodies with basement membranes in various organs
Reactivity with various basement membranes by indirect immunofluorescencea
Monoclonal
antibody
Liver Skeletal muscle
Splenic
Bile duct sinusoid Sarcolemma Fiber Epidermal Alveolar
Lung
BronchioleSinusoid
MBM4b
MBM2Ob
MBM7
MBMI5
MBM1O
MBMI4
MBMI2
MBMII
MBM2I
+
+
—
—
+
+
+
—
—
+ + + — + +
— + + — + +
+ — — — + +
+ — — — + +
+ + + — + +
+ + + — + +
+ + + — + +
+ — — + Trace —
— — — — —
+
—
+
+
+
+
+
—
—
a Membranes are indicated as reactive (+) or non-reactive (—).
MBMIO and MBM14 react in a granular pattern in all basement membranes.
b MBM4 reacts with type IV collagen and MBM2O with fibronectin.
a Type I muscle fibers only represented.
of the antibodies except MBM2O and MBM21; however, the the organs evaluated, nor with isolated lymphocytes, mono-
latter stained the intima of all vessels. cytes, polymorphonuclear leukocytes, or platelets.
None of the antibodies reacted with rat kidney. However,
MBM12, MBM15, and MBM21 stained rabbit renal basement Reactivity of monoclonal antibodies with defined antigens
membrane in patterns similar to those observed in human By ELISA, MBM4 reacted with isolated type IV collagen
kidney. (placenta) and MBM2O with fibronectin. The remaining mono-
By immunofluorescence, the monoclonal antibodies did not clonal antibodies failed to show reactivity by ELISA with
react with the surface membrane or cytoplasm of cells in any of collagen types I, III, IV, V, fibronectin, laminin, human plas-
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ma, or cryoprecipitate. In addition, the reactivity of the mono-
clonal antibodies for basement membranes as demonstrated by
indirect immunofluorescence was not inhibited by prior absorp-
tion with glutaraldehyde cross-linked human plasma or whole
plasma.
Discussion
In these studies, the characterization of antibody specificity
was based on the development of a screening analysis which
evaluated reactivity of clonal supernatants with kidney targets
by immunohistochemical methods. In other studies, the speci-
ficities of monoclonal antibodies have been defined by reactiv-
ity with purified antigens or with cell populations characterized
morphologically or functionally. However, the current method
was dictated by the recognized insolubility and heterogeneity of
isolated basement membranes and the lack of information
regarding the relationship between immunohistochemically de-
fined antigens and biochemically isolated components. With
respect to this latter concern, one long-term goal of these
studies is the development of antibodies that would permit
definitive isolation of specific basement membrane compo-
nents. This immunohistochemical approach proved to be effec-
tive in that it permitted discrimination of antibodies based upon
reactivity with certain basement membranes and not others, as
well as with specific loci or regions within the membranes. The
unique topographic differences in reactivity among the various
antibodies strongly suggest that the epitopes are located on
different molecular species. Another possibility, however, is
that the different staining observed with these antibodies could
be related to variable exposure of antigenic determinants on the
same molecules within the basement membrane. To settle this
issue definitively, isolation and characterization of the specific
components will be necessary.
By these criteria, nine different antibodies were developed,
two of which reacted with known components of the basement
membrane by ELISA. MBM4, with specificity for type IV
collagen, reacted by immunofluorescence in a pattern similar to
that previously observed with antibody to procollagen IV
derived from the EHS sarcoma [3] and identifies antigenic sites
along the internal aspect of the GBM, as well as within the
mesangium, Bowman's capsule, the TBM, and the vascular
wall. MBM2O, specific for fibronectin, stained the intima of
blood vessels, the mesangium, and the internal aspect of the
GBM, exhibiting an immunofluorescence pattern previously
observed using rabbit antibody [4].
Seven antibodies failed to react with known components of
the basement membrane including types IV and V collagen,
laminin, and fibronectin. In addition, the monoclonal antibodies
stained extracellular membranes in patterns uniquely different
from those of antibodies to these recognized antigens. Proteo-
glycan reactivity was not evaluated in this analysis because
purified antigen from renal basement membrane and its specific
antibody are not currently available.
Among the seven monoclonal antibodies, five immunohisto-
chemical phenotypes were identified in mature human kidney:
(1) MBM7 and MBM15 reacted similarly in adult kidney binding
to the lamina densa, Bowman's capsule, TBM, and vascular
walls. That these two antibodies are different is shown by the
reactivity of MBM15, but not MBM7, with droplets in fetal
tubules and rabbit basement membrane. These observations
could be explained by each antibody identifying different epi-
topes on the same molecule; alternatively, the epitopes could be
on different molecules, each of which has the same topography
in mature human kidney, (2) MBM1O and MBM14 reacted
similarly on adult kidney binding in a double-linear granular
pattern on each side of the TBM and Bowman's capsule as well
as within the mesangium and in vascular basement membranes
but not the GBM; in fetal kidney, MBM14, but not MBM1O,
reacted with the brush border of tubules indicating a difference
in the antigenic determinants with which each react. The
granular pattern of staining has been observed in the basement
membranes of all tissue samples studied. Although no structural
equivalent of this unique pattern has been recognized by
conventional electron microscopy, it has not been possible to
exclude reactivity with proteoglycan or related proteins. (3)
MBM1 I identified sites along the internal aspect of Bowman's
capsule and the TBM but not within the glomerulus. It also
stained type I but not type II skeletal muscle fibers although the
precise locus within the fiber has not been defined. (4) MBM12
reacted with the full thickness of Bowman's capsule, the
mesangium and stalk region, the TBM, but not the GBM. (5)
MBM21 which had the most restricted binding in tissue, identi-
fied an antigen in the TBM of the proximal tubules but not
within the glomerulus, Bowman's capsule, or any other tissue
evaluated.
Few prior studies of the antigenic composition of human fetal
kidneys have been published. Linder [46] described the local-
ization of polyclonal heterologous antibody to human kidney
and suggested on the basis of precipitin studies that there were
antigenic differences between fetal and postnatal kidneys. Ek-
blom [17] has shown in the embryonic mouse kidney that
fibronectin is present in the uninduced nephrogenic mesen-
chyme but disappears during induction, After invasion by a
vessel of the lower cleft of the "S" shaped nephron anlage,
these authors described reappearance of fibronectin in the
region of the primitive GBM; in later stages of glomerular
development, fibronectin was present within the developing
mesangium and GBM. Our studies demonstrate that fibronectin
was not present among the cells of the renal vesicle, but first
appeared after invasion of a vessel into the cleft of the "S"
shaped primitive nephron and the development of the primitive
GBM. This induction of synthesis of fibronectin by the primi-
tive visceral epithelial cells was shown earlier in the embryonic
mouse by Ekblom [17]. Our studies suggest that the cells of the
invading vessel probably also synthesize the fibronectin associ-
ated with the basal lamina of the vessel which becomes the
GBM through a series of branching and budding events [47].
These vascular and perivascular cells eventually differentiate to
become the endothelial and mesangial cells of the mature
glomerulus. Our observations thus support the concept of dual
origin of the components of the GBM from both epithelial and
mesangial-endothelial cell sources, as stressed by several inves-
tigators [13, 17, 19, 20, 48—50].
The distribution of type IV collagen in the developing human
kidney as revealed by reactivity with MBM4 is of special
interest since this unique basement membrane collagen is
believed to have an important role in nephron morphogenesis
and to be a critical structural component of the definitive
semipermeable glomerular filter. Reactivity was restricted to
vessel walls and the basal lamina of the ureteral bud and renal
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vesicle but not to the undifferentiated mesenchymal cells and
adjacent interstitium. The developing glomerular capillary and
mesangium contained type IV collagen at all stages of develop-
ment. These findings are similar to those of Ekblom et at [16]
and Ekblom [17] who showed that interstitial collagen (types I
and III) were diffusely present between the cells of undifferenti-
ated mouse nephrogenic mesenchyme, but type IV collagen
was absent. With induction, types I and III collagen antigens
disappeared as aggregation of the metanephric cells signaled the
beginning of organogenesis, and type IV collagen appeared
among the induced cells. These authors suggested that the loss
of interstitial collagens possibly through the action of collage-
nases may allow the cells to aggregate with the subsequent
initiation of the production of basement membrane components
[16].
An observation of special interest and potential importance
derived from the present studies was that antigens recognized
by some of the monoclonal antibodies (MBM1O, 11, 12, and 14)
were present in the GBM of the immature fetal glomerulus but
were undetectable in that region as the glomerulus matured, and
were never found in the GBM of normal adult kidneys. Electron
microscopic studies of the developing glomerulus in humans
[50] and animals [19, 20, 49, Sfl have called attention to the
presence of fibrillar and vesicular structures within the space
between the thin epithelial and endothelial lamina of the devel-
oping GBM. With further maturation of the GBM, the dual
lamina apparently fuse to give rise to the thicker central lamina
densa of the mature GBM. It seems likely that these morpholog-
ic features of GBM development may relate to the observed
presence of antigens in the fetal glomerulus which are not
identifiable in the adult structure. Whether the antigens are lost
from the GBM or are "buried" and not detectable by immuno-
histochemical techniques is unknown. Similarly, the antigen
identified by MBM1 1 was consistently localized in the mesan-
gial region of the fetal and newborn glomerulus but disappeared
or was undetectable in that locus as the glomerulus matured in
early childhood. The antigen identified by MBM21 was also
redistributed during nephron development. In the primitive
nephron this antigen was demonstrated in the basal lamina of
the ureteral bud and renal vesicle but, with maturation of the
nephrons, gradually disappeared from all sites except the TBM
of the proximal tubule.
In contrast, MBM7 and 15 were reactive with the lamina
densa of the GBM of both fetal and adult glomeruli. It is likely
that the glomerular epithelium participates in the formation of
GBM and that synthesis of certain components (identified by
MBM7 and MBMI5) occurs independent of the interaction of
endothelial or mesangial components with the metanephric
cells. Bernstein, Cheng, and Roszka [52] recently summarized
this evidence and show that glomeruli induced from mouse
metanephric mesenchyme by dorsal spinal cord formed layers
of morphologically and histochemically typical basement mem-
brane, in the absence of invading vasculature, endothelium, or
mesangial cells.
A commonality in the antigen composition of membranes in
certain tissues is apparent from these studies. For example, the
basement membrane of hepatic sinusoids, splenic sinusoids,
and muscle sarcolemma share the same antigens which are less
extensive than those of epidermal and alveolar basement mem-
branes. Certain antibodies (MBM4, MBM1O, MBM12, and
MBM14) appear to identify "common" antigens in basement
membranes of most tissues, whereas others (MBM7, MBM1L,
and MBM15) were moderately restrictive, and MBM21, the
most restrictive of all.
The interaction of antibody with basement membranes has
been recognized for many years in experimental models of renal
disease. Although the morphologic consequences resulting
from the passive administration of anti-basement membrane
antibody or from its active induction have received extensive
study, there is little information regarding the precise antigens
involved. When heterologous polyclonal antibody to human
GBM is layered on kidney, binding of IgG to all basement
membrane structures is observed by indirect immunofluores-
cence, a not unexpected finding in view of the number of
antigens demonstrated in sonicated and detergent-isolated
GBM [12]. However, a double-linear pattern of immunofluores-
cence is observed on the peripheral GBM: the outer in the
region of the lamina densa and following the course of the GBM
through its mesangial reflection and the inner merging with sites
in the mesangial zone [5]. That this is a consequence of at least
two different antibodies having different antigen specificities
has been shown conclusively in the current study in which a
mixture of MBM4 (which reacts with type IV collagen along the
internal aspect of the GBM) and MBM7 (which reacts with the
lamina densa) reproduces this double-linear pattern.
Only four monoclonal antibodies reacted with the GBM:
MBM4 which has demonstrated specificity for type IV colla-
gen; MBM2O with fibronectin; and MBM7 and MBM15 which
are of unknown specificity. On the basis of the immunohisto-
chemical phenotype, none reacts in a pattern similar to that
observed with the Goodpasture autoantibody. The latter binds
to the GBM but not the mesangium and reacts in a restricted
pattern with TBM and rarely with basement membranes in
other tissues. As further evidence for the differences between
the monoclonal antibodies and the Goodpasture antibody is the
observation that the latter does not bind to the GBM of some
males with familial nephritis whereas MBM4, MBM7, and
MBM15 bind normally [53]. The failure to develop a monoclo-
nal antibody in the mouse reactive with the Goodpasture
antigen(s) may be related to the fact that it is present in the
GBM of mice and therefore is not recognized as an immunogen.
Although autoantibodies to human TBM have been observed in
certain clinical situations [54], it is not known whether these
identify the same antigens that are reactive with any of the
monoclonal antibodies.
The relationship of antigens identified by seven of the mono-
clonal antibodies to biochemically-isolated basement mem-
brane components is largely unexplored. Although extensively
studied, the precise interaction between the collagen and non-
collagen glycoprotein components of human basement mem-
brane has not been resolved [55—58]. Recent studies of Timpl et
al [59] suggest that the collagenous matrix of basement mem-
brane consists of a network of type IV collagen molecules,
inter-connected and cross-linked by way of collagen and non-
collagen domains. In addition, polypeptide heterogeneity has
been verified as a characteristic feature of GBM irrespective of
the isolation procedure [60]. In part, this finding may be
explained by the observation that isolated GBM is heteroge-
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neous with respect to its constituent antigens [12]. Evidence for
morphologic heterogeneity also has been deduced from the
variable effects of enzymatic digestion on different membranes
or on specific regions within membranes [61].
Although there is no information, to our knowledge, regard-
ing the nature of the antigenic determinants (or the parent
molecules) reactive with these antibodies or the absolute
amounts present within the membrane, these studies demon-
strate a remarkable antigenic heterogeneity. For example,
assuming that MBM7 and MBM15 as well as MBM1O and
MBM14 each identify different epitopes on the same respective
molecules, there are at least five different components identi-
fied by monoclonal antibodies on TBM (MBM7 or MBM15,
MBM1O orMBM14, MBM11, MBM12, MBM21); to these must
be added the recognizable molecules, that is, types IV and V
collagen and laminin. A similar heterogeneity exists in the
basement membranes of other organs. Whether some of these
antigens are distributed in site-specific regions within the mem-
brane similar to that demonstrated in GBM must await the
further refinement of immunoelectron microscopy. Neverthe-
less, these investigations should provide a basis for further
mapping of basement membrane antigens, the definitive isola-
tion and characterization of immunoreactive components, and
detailed studies of changes associated with disease.
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